Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daprodustat vs epoetin for renal anemia in non-dialysis CKD (Phase III, China)
CTR20261934Phase 3Active
- Sponsor
- Bocimed Pharmaceutical
- Start
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of daprodustat in anemia of chronic kidney disease, sponsored by Bocimed Pharmaceutical. Started May 2026; status: active.
02
Drugs
daprodustat
03
Conditions
anemia of chronic kidney disease
Beyond the preview
Go deeper on CTR20261934.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20261934.